✦ LIBER ✦

Early immunonutrition in moderately burned patients: A prospective, double masked, randomized controlled trial

✍ Scribed by J. Toledo; S. Danilla; P. Léniz; J. Piñeros; A. Fernández; P. Roldán; W. Calderón

Book ID: 116329737
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 110 KB
Volume: 33
Category: Article
ISSN: 0305-4179
DOI: 10.1016/j.burns.2006.10.147

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OP006 PERIOPERATIVE IMMUNONUTRITION IN L

OP006 PERIOPERATIVE IMMUNONUTRITION IN LIVER TRANSPLANTATION: RESULTS OF A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL

✍ L.D. Plank; S. Mathur; E.J. Gane; L. Gillanders; K. McIlroy; J.L. McCall 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Bevacizumab vs Ranibizumab for Age-Relat

Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial

✍ Manju L. Subramanian; Steven Ness; Gelareh Abedi; Ednan Ahmed; Mary Daly; Edward 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 740 KB

Bevacizumab vs Ranibizumab for Age-Relat

Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial

✍ Sean P. Donahue; Franco Recchia; Paul Sternberg Jr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 80 KB

A randomized, double-masked, placebo-con

A randomized, double-masked, placebo-controlled trial of chlorthalidone and bone loss in elderly women

✍ R. D. Wasnich; J. W. Davis; Y. -F. He; H. Petrovich; P. D. Ross 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 596 KB

Pain relief in laparoscopic tubal ligati

Pain relief in laparoscopic tubal ligation using intraperitoneal lignocaine: a double masked randomized controlled trial

✍ Attibele Palaksha Manjunath; Nidhika Chhabra; Shivarudraiah Girija; Sreekumaran 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 224 KB

Double-blind, randomized, controlled tri

Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients

✍ Matthew B. Stern; Kenneth L. Marek; Joseph Friedman; Robert A. Hauser; Peter A. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 2 views

## Abstract Rasagiline (__N__‐propargyl‐1(__R__)‐aminoindan) mesylate is a potent, selective, and irreversible monoamine oxidase‐B inhibitor. This study was designed to evaluate the safety, tolerability, and preliminary efficacy of rasagiline monotherapy in early Parkinson's disease (PD) patients n